| Literature DB >> 33623693 |
Irati Tapia González1,2,3, Vicent Esteve Simó1,2, Sara Ibañez Pallares1,4, Fátima Moreno Guzman2, Miquel Fulquet Nicolás2, Verónica Duarte Gallego2, Anna Saurina Solé2, Mónica Pou Potau2, Montserrat Yeste Campos4, Manel Ramírez de Arellano Serna2.
Abstract
INTRODUCTION: Arteriovenous fistula (AVF) is the gold standard for vascular access (VA) for end-stage chronic kidney disease (CKD) patients. Post-operative exercises may help to improve maturation. Nevertheless, scarce scientific evidence has been reported about their utility to date. Our objective was to assess the effect of a post-operative isometric exercise programme on native VA maturation in patients with stage 5-5D CKD.Entities:
Keywords: chronic kidney disease; isometric exercise; maturation; vascular access
Year: 2020 PMID: 33623693 PMCID: PMC7886562 DOI: 10.1093/ckj/sfz194
Source DB: PubMed Journal: Clin Kidney J ISSN: 2048-8505
FIGURE 1Isometric exercises of the distal region: (a) pressure with rubber ball, (b) interpalmar pressure, (c) pressure digital clamp, (d) adduction–abduction, (e) prone cuff supination, (f) pressure cuff, (g) flexoextension with a weight of 1 kg, (h) pressure clamp and (i) interdigital pressure.
FIGURE 2Isometric exercises of the proximal region: (a) proximal digital pressure, (b) digital distal pressure, (c) prone supination with 1 kg, (d) weight lifting with 1 kg, (e) digital pressure on wall and (f) stretch with elastic band.
Sociodemographic parameters
| Parameters | Global | EG ( | CG ( | P-value |
|---|---|---|---|---|
| Age (years) | 68.6 ± 13.0 | 67.3 ± 14.2 | 69.9 ± 11.9 | 0.199 |
| Sex (men), % ( | 71.3 (42) | 66.7 (19) | 73.3 (22) | 0.500 |
| Charlson Comorbidity Index | 6.9 ± 2.4 | 6.9 ± 2.8 | 7.3 ± 3.1 | 0.124 |
| Hypertension, % ( | 91.7 (55) | 86.7 (26) | 96.7 (29) | 0.177 |
| Diabetes mellitus, % ( | 46.7 (28) | 46.7 (14) | 46.7 (14) | 0.602 |
| Dyslipidaemia, % ( | 65 (39) | 66.7 (20) | 63.3 (19) | 0.500 |
| Smokers, % ( | 31.7 (19) | 42.1 (8) | 57.9 (11) | 0.290 |
| Ischaemic heart disease, % ( | 26.7 (16) | 16.7 (5) | 36.7 (11) | 0.072 |
| Handgrip (kg) | 22.2 | 20.7 | 23.7 | 0.427 |
| Localization of arteriovenous fistula | ||||
| Distal, % ( | 60 (36) | 53.3 (16) | 66.7 (20) | 0.443 |
| Left, % ( | 80 (48) | 80 (24) | 80 (24) | 0.443 |
| Preoperative variables | ||||
| Lower arm CV diameter (mm) | 2.6 ± 0.7 | 2.7 ± 0.5 | 2.5 ± 0.7 | 0.218 |
| Upper arm CV diameter (mm) | 3.3 ± 0.9 | 3.5 ± 0.6 | 3.2 ± 1.2 | 0.119 |
| Upper arm BV diameter (mm) | 3.9 ± 1.2 | 4.1 ± 1.1 | 3.8 ± 1.3 | 0.259 |
| Bracial artery flow (mL/min) | 137.7 ± 35.9 | 142.8 ± 35.2 | 134.6 ± 36.6 | 0.870 |
Results are expressed by mean ± SD unless stated otherwise.
P <0.05 indicates statistical significance.
Biochemical parameters
| EG ( | CG ( | |||||
|---|---|---|---|---|---|---|
| Parameters | Baseline | End of study | P-value | Baseline | End of study | P-value |
| Main biochemical data | ||||||
| Glucose (mg/dL) | 157.2 ± 51.2 | 153.8 ± 72.4 | 0.845 | 152.2± 32.1 | 154 ± 33.1 | 0.821 |
| Creatinine (mg/dL) | 8.1 ± 2.3 | 8.2 ± 3.1 | 0.924 | 7.8 ± 2.3 | 7.8 ± 2.6 | 0.985 |
| K (mEq/L) | 5.3 ± 0.7 | 5.6 ± 0.8 | 0.726 | 5.3 ± 0.9 | 5.2 ± 1.1 | 0.964 |
| Ca (mg/dL) | 8.8 ± 0.8 | 8.9 ± 0.2 | 0.931 | 8.8 ± 0.4 | 8.9 ± 0.8 | 0.863 |
| P (mg/dL) | 4.4 ± 1.2 | 4.3 ± 1.2 | 0.866 | 4.5 ± 1.4 | 4.5 ± 1.3 | 0.978 |
| i-PTH (pg/mL) | 189.2 ± 156.2 | 170.1 ± 132.6 | 0.872 | 178.8 ± 114 | 181.7 ± 137.9 | 0.972 |
| Nutritional parameters | ||||||
| Albumin (g/dL) | 3.8 ± 0.3 | 3.9 ± 0.3 | 0.722 | 3.8 ± 0.3 | 3.9 ± 0.4 | 0.813 |
| Pre-albumin (mg/dL) | 35.3 ± 11.2 | 35.4 ± 8.8 | 0.789 | 33.6 ± 11.1 | 33.1 ± 9.5 | 0.850 |
| Total cholesterol (mg/dL) | 140.1 ± 54.2 | 147.1± 57.1 | 0.346 | 151.2 ± 32.4 | 148.9 ± 34.5 | 0.721 |
| HDL cholesterol (mg/dL) | 42.6 ± 11.2 | 40.2 ± 11.9 | 0.597 | 42.5 ± 10.3 | 41.6 ± 41.6 | 0.623 |
| Triglycerides (mg/dL) | 153.9 ± 83.5 | 156.6 ± 75.6 | 0.724 | 159.3 ± 69.6 | 154.2 ± 73.4 | 0.497 |
| LDL cholesterol (mg/dL) | 66.7 ± 44.1 | 73.4 ± 46.8 | 0.432 | 69.2 ± 65.6 | 65.7 ± 30.5 | 0.526 |
| Haemogram data | ||||||
| Haemoglobin (g/dL) | 11.6 ± 1.5 | 11.7 ± 1.3 | 0.793 | 11.8 ± 1.4 | 11.6 ± 1.1 | 0.726 |
| Ferritin (ng/mL) | 434.5 ± 271.1 | 412 ± 269.4 | 0.820 | 396.8 ± 157.1 | 425.2 ± 213.4 | 0.769 |
Results are expressed by mean ± SD.
P < 0.05 indicates statistical significance.
K, potassium; Ca, calcium; P, phosphorus; i-PTH, intact parathyroid hormone; HDL, high-density lipoprotein; LDL, low density lipoprotein.
Muscle strength and ultrasound data
| EG ( | CG ( | |||||
|---|---|---|---|---|---|---|
| Variables | Baseline | End of study | P-value | Baseline | End of study | P-value |
| Muscle strength data (kg) | ||||||
| Handgrip | 20.7 ± 8.1 | 25.1 ± 10.3 | 0.001* | 23.7 ± 9.2 | 23.9 ± 9.3 | 0.703 |
| Ultrasound data | ||||||
| Outflow vein diameter (mm) | 3.3 ± 0.8 | 6.5 ± 1.9 | 0.013* | 2.9 ± 0.6 | 6.1 ± 1.4 | 0.004* |
| Braquial blood flow rate (mL/min) | 142.8 ± 35.2 | 1647.3 ± 999.9 | 0.001* | 134.6 ± 36.6 | 1270.1 ± 653.7 | 0.001* |
Results are expressed by mean ± SD.
Statistical significance is indicated by *P < 0.05.
Clinical and ultrasound maturation rates
| 4 weeks | 8 weeks | |||||
|---|---|---|---|---|---|---|
| Variables | EG ( | CG ( | P-value | EG ( | CG ( | P-value |
| Clinical maturation, % ( | 70 (21) | 33.3 (10) | 0.009* | 76.7 (23) | 33.3 (10) | 0.002* |
| Ultrasound maturation, % ( | 80 (24) | 40 (12) | 0.003* | 83.3 (25) | 43.3 (13) | 0.003* |
| Distal territory, % ( | ||||||
| Clinical maturation | 60 (12) | 40 (8) | 0.038* | 58.3 (14) | 41.7 (10) | 0.020* |
| Ultrasound maturation | 64.7 (11) | 35.3 (6) | 0.023* | 63.2 (12) | 36.8 (7) | 0.019* |
| Proximal territory, % ( | ||||||
| Clinical maturation | 64.3 (9) | 20 (2) | 0.040* | 71.4 (10) | 20 (2) | 0.018* |
| Ultrasound maturation | 85.7 (12) | 40 (4) | 0.028* | 92.9 (13) | 60 (6) | 0.049* |
Statistical significance is indicated by *P < 0.05.